Hope and Resilience: A Case of Mesothelioma Long-Term Survival
| |

Hope and Resilience: A Case of Mesothelioma Long-Term Survival

ByHolly Zink

A new study highlights how important early diagnosis and effective treatment are to long-term survival. Malignant peritoneal mesothelioma is a type of cancer caused by asbestos. It develops in the abdominal cavity. This cancer occurs in less than 1,000 people in the United States every year. The Importance of Early Detection Symptoms of mesothelioma may take decades after asbestos exposure to appear in the affected person. Most of the common symptoms occur around the abdomen, like pain and swelling. Other symptoms could be night sweats and fever. To diagnose mesothelioma, doctors will usually use a combination of scans and biopsies. Treatment for mesothelioma can include surgery, chemotherapy, and radiation. A Japanese Case Study on Long-Term Survival In this case, a…

Bortezomib Shows Promise as New Mesothelioma Treatment
|

Bortezomib Shows Promise as New Mesothelioma Treatment

ByHolly Zink

A drug called Bortezomib can help treat malignant mesothelioma when given directly into the area affected by the cancer. This interesting finding comes from a team of scientists from Italy. They tested Bortexomib on mesothelioma cells to find out if it can stop cancer cell growth. New Research for New Treatments Malignant mesothelioma is a rare cancer caused by asbestos exposure. It develops from the thin layer of tissue that covers many of the body’s internal organs, like the lungs and abdominal cavity. The treatment options for malignant mesothelioma are limited. Conventional treatments for mesothelioma consist of chemotherapy, surgery, and sometimes radiation therapy. Even with treatment, the prognosis for mesothelioma is not good. The median survival rate of patients with…

Largest Study Shows HIPEC Treatment Effective for Mesothelioma
| |

Largest Study Shows HIPEC Treatment Effective for Mesothelioma

ByHolly Zink

Hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) could be an effective treatment for malignant peritoneal mesothelioma (MPM). This is the finding of one of the largest and longest studies on the use of CRS-HIPEC to treat MPM. Researchers from the Atrium Health Wake Forest Baptist Comprehensive Cancer Center looked at data from 111 patients over 28 years. Diagnosed with MPM MPM is an aggressive cancer caused by asbestos. Symptoms of MPM are usually noticed first in the abdomen or the gastrointestinal system. People might feel abdominal pain or swelling, fever, and night sweats. MPM occurs in less than 1,000 people in the United States every year and accounts for about 20-25% of all mesothelioma cases. Patients diagnosed with MPM have longer life expectancy…